Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156313 | SCV000206031 | uncertain significance | not specified | 2014-02-17 | criteria provided, single submitter | clinical testing | The Arg28493His variant in TTN has not been previously reported in individuals w ith cardiomyopathy or in large population studies. Computational analyses (bioch emical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do n ot provide strong support for or against an impact to the protein. Additional in formation is needed to fully assess the clinical significance of this variant. |
Gene |
RCV000184991 | SCV000237775 | likely benign | not provided | 2020-02-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000643636 | SCV000765323 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2018-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372023 | SCV002667184 | likely benign | Cardiovascular phenotype | 2020-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |